• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

概念验证:SCENTinel 1.1可快速鉴别与新冠病毒相关的嗅觉障碍。

Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.

作者信息

Hunter Stephanie R, Hannum Mackenzie E, Pellegrino Robert, O'Leary Maureen A, Rawson Nancy E, Reed Danielle R, Dalton Pamela H, Parma Valentina

机构信息

Monell Chemical Senses Center, Philadelphia, PA.

Department of Psychology, Temple University, Philadelphia, PA.

出版信息

medRxiv. 2022 Nov 8:2022.03.23.22272807. doi: 10.1101/2022.03.23.22272807.

DOI:10.1101/2022.03.23.22272807
PMID:35350197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8963695/
Abstract

It is estimated that 20-67% of those with COVID-19 develop olfactory disorders, depending on the SARS-CoV-2 variant. However, there is an absence of quick, population-wide olfactory tests to screen for olfactory disorders. The purpose of this study was to provide a proof-of-concept that SCENTinel 1.1, a rapid, inexpensive, population-wide olfactory test, can discriminate between anosmia (total smell loss), hyposmia (reduced sense of smell), parosmia (distorted odor perception), and phantosmia (odor sensation without a source). Participants were mailed a SCENTinel 1.1 test, which measures odor detection, intensity, identification, and pleasantness, using one of four possible odors. Those who completed the test (N = 381) were divided into groups based on their self-reported olfactory function: quantitative olfactory disorder (anosmia or hyposmia, N = 135), qualitative olfactory disorder (parosmia and/or phantosmia; N = 86), and normosmia (normal sense of smell; N = 66). SCENTinel 1.1 accurately discriminates quantitative olfactory disorders, qualitative olfactory disorders, and normosmia groups. When olfactory disorders were assessed individually, SCENTinel 1.1 discriminates between hyposmia, parosmia and anosmia. Participants with parosmia rated common odors less pleasant than those without parosmia. We provide proof-of-concept that SCENTinel 1.1, a rapid smell test, can discriminate quantitative and qualitative olfactory disorders, and is the only direct test to rapidly discriminate parosmia.

摘要

据估计,20%-67%的新冠肺炎患者会出现嗅觉障碍,这取决于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的变体。然而,目前缺乏快速、针对全体人群的嗅觉测试来筛查嗅觉障碍。本研究的目的是提供一个概念验证,即SCENTinel 1.1这种快速、廉价、针对全体人群的嗅觉测试能够区分嗅觉丧失(完全嗅觉丧失)、嗅觉减退(嗅觉减弱)、嗅觉倒错(气味感知扭曲)和嗅觉幻觉(无来源的气味感觉)。研究人员给参与者邮寄了一份SCENTinel 1.1测试,该测试使用四种可能气味中的一种来测量气味检测、强度、识别和愉悦度。完成测试的参与者(N = 381)根据其自我报告的嗅觉功能被分为几组:定量嗅觉障碍(嗅觉丧失或嗅觉减退,N = 135)、定性嗅觉障碍(嗅觉倒错和/或嗅觉幻觉;N = 86)和嗅觉正常(正常嗅觉;N = 66)。SCENTinel 1.1能够准确区分定量嗅觉障碍、定性嗅觉障碍和嗅觉正常组。当单独评估嗅觉障碍时,SCENTinel 1.1能够区分嗅觉减退、嗅觉倒错和嗅觉丧失。有嗅觉倒错的参与者对常见气味的愉悦度评价低于没有嗅觉倒错的参与者。我们提供了概念验证,即SCENTinel 1.1这种快速嗅觉测试能够区分定量和定性嗅觉障碍,并且是唯一能快速区分嗅觉倒错的直接测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/585115ad84ef/nihpp-2022.03.23.22272807v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/2d519432bace/nihpp-2022.03.23.22272807v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/3d56b7fd13c3/nihpp-2022.03.23.22272807v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/45a515a9671f/nihpp-2022.03.23.22272807v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/585115ad84ef/nihpp-2022.03.23.22272807v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/2d519432bace/nihpp-2022.03.23.22272807v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/3d56b7fd13c3/nihpp-2022.03.23.22272807v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/45a515a9671f/nihpp-2022.03.23.22272807v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89f0/9749524/585115ad84ef/nihpp-2022.03.23.22272807v2-f0004.jpg

相似文献

1
Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.概念验证:SCENTinel 1.1可快速鉴别与新冠病毒相关的嗅觉障碍。
medRxiv. 2022 Nov 8:2022.03.23.22272807. doi: 10.1101/2022.03.23.22272807.
2
Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.概念验证:SCENTinel 1.1 快速区分与 COVID-19 相关的嗅觉障碍。
Chem Senses. 2023 Jan 1;48. doi: 10.1093/chemse/bjad002.
3
SCENTinel 1.0: Development of a Rapid Test to Screen for Smell Loss.SCENTinel 1.0:一种用于嗅觉丧失筛查的快速检测方法的开发。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab012.
4
Effects of genetics on odor perception: Can a quick smell test effectively screen everyone?遗传学对气味感知的影响:快速嗅觉测试能否有效筛查所有人?
Chem Senses. 2024 Jan 1;49. doi: 10.1093/chemse/bjae025.
5
: development of a rapid test to screen for smell loss.用于筛查嗅觉丧失的快速检测方法的开发。
medRxiv. 2020 Dec 11:2020.12.10.20244301. doi: 10.1101/2020.12.10.20244301.
6
Prevalence and correlates of parosmia and phantosmia among smell disorders.嗅觉障碍患者中嗅觉异常和幻嗅的患病率及相关因素。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab046.
7
Using SCENTinel® to predict SARS-CoV-2 infection: insights from a community sample during dominance of Delta and Omicron variants.使用SCENTinel®预测新型冠状病毒2型感染:来自德尔塔和奥密克戎变异株主导时期社区样本的见解
Front Public Health. 2024 Apr 10;12:1322797. doi: 10.3389/fpubh.2024.1322797. eCollection 2024.
8
Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination.嗅觉命名法:澄清嗅觉障碍(包括嗅觉减退、嗅觉丧失、嗅觉减退、嗅觉正常、嗅觉过度、嗅觉过敏、幻嗅和嗅觉幻觉)相关术语和定义的协调努力。
ORL J Otorhinolaryngol Relat Spec. 2023;85(6):312-320. doi: 10.1159/000530211. Epub 2023 Apr 14.
9
Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.定性嗅觉功能障碍与 COVID-19:基于证据的综述及对临床医生的建议。
Am J Rhinol Allergy. 2023 Jan;37(1):95-101. doi: 10.1177/19458924221120117. Epub 2022 Aug 11.
10
Low to moderate genetic influences on the rapid smell test SCENTinel.嗅觉快速检测SCENTinel受低至中等程度的基因影响。
medRxiv. 2023 May 21:2023.05.14.23289965. doi: 10.1101/2023.05.14.23289965.

本文引用的文献

1
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.英国与奥密克戎相关的新冠病毒症状变化
Clin Infect Dis. 2022 Aug 3;76(3):e133-41. doi: 10.1093/cid/ciac613.
2
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.在年轻成年人中进行 SARS-CoV-2 人体挑战的安全性、耐受性和病毒动力学。
Nat Med. 2022 May;28(5):1031-1041. doi: 10.1038/s41591-022-01780-9. Epub 2022 Mar 31.
3
Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.嗅觉训练改良法是治疗新冠病毒引起的嗅觉障碍的有效方法。
Laryngoscope. 2022 Jul;132(7):1433-1438. doi: 10.1002/lary.30101. Epub 2022 Mar 11.
4
Clinical factors associated with lower health scores in COVID-19-related persistent olfactory dysfunction.与 COVID-19 相关持续性嗅觉功能障碍患者健康评分较低相关的临床因素。
Int Forum Allergy Rhinol. 2022 Oct;12(10):1242-1253. doi: 10.1002/alr.22978. Epub 2022 Jan 31.
5
Patients' Perspectives on Qualitative Olfactory Dysfunction: Thematic Analysis of Social Media Posts.患者对定性嗅觉功能障碍的看法:社交媒体帖子的主题分析
JMIR Form Res. 2021 Dec 14;5(12):e29086. doi: 10.2196/29086.
6
Prevalence and correlates of parosmia and phantosmia among smell disorders.嗅觉障碍患者中嗅觉异常和幻嗅的患病率及相关因素。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab046.
7
SCENTinel 1.0: Development of a Rapid Test to Screen for Smell Loss.SCENTinel 1.0:一种用于嗅觉丧失筛查的快速检测方法的开发。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjab012.
8
Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms.近期嗅觉丧失是近期有呼吸道症状个体中 COVID-19 的最佳预测指标。
Chem Senses. 2021 Jan 1;46. doi: 10.1093/chemse/bjaa081.
9
Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.目的:与主观方法相比,客观感觉测试方法显示 COVID-19 阳性患者的嗅觉丧失发生率更高:系统评价和荟萃分析。
Chem Senses. 2020 Dec 5;45(9):865-874. doi: 10.1093/chemse/bjaa064.
10
Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).嗅觉愉悦感知评估:嗅吸棒嗅觉障碍测试(SSParoT)。
Sci Rep. 2020 Oct 22;10(1):18019. doi: 10.1038/s41598-020-74967-0.